All posts by: Michael Zand

About Michael Zand

Singapore scientists discover new RNA processing pathway important in human … – Science Codex

Singapore scientists discover new RNA processing pathway important in human …Science CodexSON was discovered to be essential for converting differentiated cells into pluripotent stem cells . In addition, SON promotes correct splicing of a particular group of RNAs, including those coding for essential hESC regulators, and thereby helps hESCs … …read more   &nbs… Continue reading

2013-09-09 NEWS

StemCells, Inc. Publishes Comprehensive Review of Results From HuCNS-SC … – GlobeNewswire (press release)

StemCells, Inc. Publishes Comprehensive Review of Results From HuCNS-SC …GlobeNewswire (press release)NEWARK, Calif., Sept. 9, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced the publication of a comprehensive overview describing the therapeutic potential and results from early clinical trials of the Company’s proprietary … and more …read more   &nbs… Continue reading

2013-09-09 NEWS

International Stem Cell Corporation Advances Parkinson’s Disease Program … – Marketwire (press release)

International Stem Cell Corporation Advances Parkinson’s Disease Program …Marketwire (press release)The meeting was a significant step towards clinical studies to evaluate the use of stem cell-derived neuronal cells to treat Parkinson’s disease (PD). By bringing together leading experts from throughout North America in the field of cell therapy and … …read more   &nbs… Continue reading

2013-09-09 NEWS

International Stem Cell Corporation Advances Parkinson’s Disease Program … – Marketwire (press release)

International Stem Cell Corporation Advances Parkinson’s Disease Program …Marketwire (press release)The meeting was a significant step towards clinical studies to evaluate the use of stem cell-derived neuronal cells to treat Parkinson’s disease (PD). By bringing together leading experts from throughout North America in the field of cell therapy and … …read more   &nbs… Continue reading

2013-09-09 NEWS

Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling … – Stockhouse

Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling …StockhouseTORONTO, ONTARIO–(Marketwired – Sept. 9, 2013) – Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell– related therapeutics, today announced that it has advanced its CD47 … and more …read more   &nbs… Continue reading

2013-09-09 NEWS